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Opinion
The worldwide prevalence of diabetes is reported as 463 million 
(substantially exceeding the US population) and it is projected to 
rise to 700 million by 2045 [1]. Specifically, in the United States, 1 in 
5 diabetics remain undiagnosed, which can only increase the current 
estimate on number of cases and also the scope to its management 
[2]. It has been well established that a longstanding history of 
uncontrolled diabetes can lead to multi-organ dysfunction, such as 
nephropathy, peripheral vascular disease, and diabetic retinopathy 
(DR).
DR is a microvascular complication and a major cause of 
blindness in the world. The rapid formation of new blood vessels 
in the retina will lead to induce microaneurysms and a loss of 
vasculature integrity. DR not only affects the eye, but also has a 
detrimental impact on a person’s quality of life. A cross-sectional, 
population-based study assessed the health-related quality of life 
and the impact of DR in 1,064 participants. The visual impairment 
related to DR was found to have a profound effect on social 
factors, such as mobility, independence, and mental health [3]. 
This study suggests that people with diabetes, who receive proper 
management of their disease, are living healthier and happier lives.
When it comes to preventing diabetes-related complications, 
patients are generally advised to have good control over one’s blood 
sugar levels and blood pressure from an early standpoint. Making 
 
lifestyle modifications can delay the onset of DR, however, since this 
complication is initially asymptomatic, it’s difficult to make an early 
prognosis. It is not until the later stages of DR that symptoms begin 
to manifest with various visual disturbances. Current treatments 
are focused to preserve vision with the use of vascular endothelial 
growth factor inhibitors to attenuate growth of new blood vessels 
or laser photocoagulation to seal leaking blood vessels in the retina.
However, these treatments often impose a financial burden on 
patients, given the need for frequent administration. This suggests 
a need for cost-effective therapeutic approaches aimed toward 
preventing DR, while encouraging continuity of care. A novel 
molecular pathway on the pathogenesis of DR may serve to identify 
potential therapeutic targets for early intervention.
One of the hallmarks of early DR is the loss of human retinal 
pericytes (HRP) through apoptosis. However, the exact mechanisms 
that promote pericyte dropout are unknown. Pericytes are 
contractile cells that envelop the endothelial cells of capillaries. 
They help maintain adequate blood flow, as well as the integrity 
of the blood-brain barrier [4,5]. There are several proposed 
signaling pathways on the pathogenesis of DR. One of them involve 
the inflammatory response to diabetes in which HRP apoptosis is 
caused by TGFβ secreted by macrophages of the immune system 
when they enter the retina. TGFβ results in an increase of TGFβ-
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Abstract
Diabetic retinopathy (DR) is a complication of diabetes due to damage of blood vessels in the retina. Aside from being a major cause of blindness 
in the world, DR also has a significant impact on quality of life. Although there are methods to delay the progression of DR, there are no existing 
therapeutic regimens for early intervention. Thus, it is critical to develop cost-effective therapies towards preventing DR development.
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induced Gene Human Clone 3 (BIGH3) that binds to integrin 
receptors in HRP, leading to apoptosis [6].
BIGH3 is an extracellular pro-apoptotic protein that 
accumulates in the retinal vessels. BIGH3 mediates cellular 
adhesion, proliferation, and apoptosis through an autocrine 
signalling mechanism by interacting with HRP integrin receptors 
[7,8]. Previous studies have demonstrated that treatment of 
increased concentrations of TGFβ causes a rise in BIGH3 synthesis 
in mammalian pericytes and endothelial cells, followed by 
apoptosis [9,10]. This suggests BIGH3-mediated apoptosis in HRP 
may contribute to the progression of DR.
Although there is supporting evidence of an association 
between BIGH3 and DR, the complete molecular pathway of 
BIGH3-mediated apoptosis in HRP warrants further investigation. 
As HRP are vital to maintaining retinal vasculature, it is critical to 
find an innovative molecular pathway and therapy targets to inhibit 
the BIGH3-bound integrin. Overall, a molecular therapy from this 
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